X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Under the partnership, EVERSANA will support the expansion of its portfolio of pain and endocrinology products in the U.S., including Flector (diclofenac epolamine), a topical prescription therapy for acute pain due to minor strains, sprains, and contusions.
Lead Product(s): Diclofenac Epolamine
Therapeutic Area: Neurology Product Name: Flector
Highest Development Status: ApprovedProduct Type: Small molecule
Recipient: Eversana
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership May 22, 2023
Details:
Diclofenac epolamine topical system 1.3% is a prescription nonsteroidal anti-inflammatory (NSAID) medicated patch indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions.
Lead Product(s): Diclofenac Epolamine
Therapeutic Area: Neurology Product Name: Diclofenac Epolamine-Generic
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 03, 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
